108 related articles for article (PubMed ID: 32653100)
1. Insomnia and its association with quality of life in women with ovarian cancer.
Ross TL; DeFazio A; Friedlander M; Grant P; Nagle CM; Williams M; Webb PM; Beesley VL;
Gynecol Oncol; 2020 Sep; 158(3):760-768. PubMed ID: 32653100
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor.
Price MA; Zachariae R; Butow PN; deFazio A; Chauhan D; Espie CA; Friedlander M; Webb PM; ;
Eur J Cancer; 2009 Dec; 45(18):3262-70. PubMed ID: 19540748
[TBL] [Abstract][Full Text] [Related]
3. When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer.
Beesley VL; Webber K; Nagle CM; DeFazio A; Obermair A; Williams M; Friedlander M; Webb PM;
Gynecol Oncol; 2020 Oct; 159(1):179-186. PubMed ID: 32773150
[TBL] [Abstract][Full Text] [Related]
4. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis.
Clevenger L; Schrepf A; Degeest K; Bender D; Goodheart M; Ahmed A; Dahmoush L; Penedo F; Lucci J; Thaker PH; Mendez L; Sood AK; Slavich GM; Lutgendorf SK
Cancer; 2013 Sep; 119(17):3234-41. PubMed ID: 23797955
[TBL] [Abstract][Full Text] [Related]
5. Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.
Moss JL; Murphy J; Filiaci VL; Wenzel LB; Minasian L; Temkin SM
Support Care Cancer; 2019 Feb; 27(2):531-538. PubMed ID: 30003341
[TBL] [Abstract][Full Text] [Related]
6. Sleep Characteristics and Risk of Ovarian Cancer Among Postmenopausal Women.
Liang X; Harris HR; Hendryx M; Shadyab AH; Hale L; Li Y; Crane TE; Cespedes Feliciano EM; Stefanick ML; Luo J
Cancer Prev Res (Phila); 2021 Jan; 14(1):55-64. PubMed ID: 32917642
[TBL] [Abstract][Full Text] [Related]
7. Insomnia and circadian sleep disorders in ovarian cancer: Evaluation and management of underestimated modifiable factors potentially contributing to morbidity.
Palagini L; Miniati M; Massa L; Folesani F; Marazziti D; Grassi L; Riemann D
J Sleep Res; 2022 Jun; 31(3):e13510. PubMed ID: 34716629
[TBL] [Abstract][Full Text] [Related]
8. [A connection between insomnia and psychiatric disorders in the French general population].
Ohayon MM; Lemoine P
Encephale; 2002; 28(5 Pt 1):420-8. PubMed ID: 12386543
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns and associated factors in patients with advanced epithelial ovarian cancer: a population-based study.
Zijlstra M; Timmermans M; Fransen H; van der Aa M; Reyners A; Raijmakers N; van de Poll-Franse L
Int J Gynecol Cancer; 2019 Jul; 29(6):1032-1037. PubMed ID: 31263022
[TBL] [Abstract][Full Text] [Related]
10. Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer.
Bean HR; Stafford L; Little R; Diggens J; Ftanou M; Alexander M; Francis PA; Bei B; Wiley JF
Trials; 2020 Mar; 21(1):295. PubMed ID: 32216832
[TBL] [Abstract][Full Text] [Related]
11. The burden of insomnia on individual function and healthcare consumption in Australia.
Bin YS; Marshall NS; Glozier N
Aust N Z J Public Health; 2012 Oct; 36(5):462-8. PubMed ID: 23025369
[TBL] [Abstract][Full Text] [Related]
12. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
[TBL] [Abstract][Full Text] [Related]
13. [Sleep and insomnia markers in the general population].
Ohayon MM; Lemoine P
Encephale; 2004; 30(2):135-40. PubMed ID: 15107715
[TBL] [Abstract][Full Text] [Related]
14. The association of insomnia and quality of life: Sao Paulo epidemiologic sleep study (EPISONO).
Lucena L; Polesel DN; Poyares D; Bittencourt L; Andersen ML; Tufik S; Hachul H
Sleep Health; 2020 Oct; 6(5):629-635. PubMed ID: 32335038
[TBL] [Abstract][Full Text] [Related]
15. Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms.
Bolge SC; Balkrishnan R; Kannan H; Seal B; Drake CL
Menopause; 2010; 17(1):80-6. PubMed ID: 19730276
[TBL] [Abstract][Full Text] [Related]
16. Who is at risk for having persistent insomnia symptoms? A longitudinal study in the general population in Korea.
Suh S; Yang HC; Fairholme CP; Kim H; Manber R; Shin C
Sleep Med; 2014 Feb; 15(2):180-6. PubMed ID: 24457162
[TBL] [Abstract][Full Text] [Related]
17. Chronic difficulties are associated with poorer psychosocial functioning in the first year post-diagnosis in epithelial ovarian cancer patients.
Garvin L; Slavich GM; Schrepf A; Davis LZ; Thaker PH; Goodheart MJ; Cole SW; Sood AK; Lutgendorf SK
Psychooncology; 2021 Jun; 30(6):954-961. PubMed ID: 33760306
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of insomnia for Canadians aged 6 to 79.
Chaput JP; Yau J; Rao DP; Morin CM
Health Rep; 2018 Dec; 29(12):16-20. PubMed ID: 30566205
[TBL] [Abstract][Full Text] [Related]
19. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
20. A multinational study of sleep disorders during female mid-life.
Blümel JE; Cano A; Mezones-Holguín E; Barón G; Bencosme A; Benítez Z; Bravo LM; Calle A; Flores D; Espinoza MT; Gómez G; Hernández-Bueno JA; Laribezcoa F; Martino M; Lima S; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Sánchez H; Tserotas K; Vallejo MS; Witis S; Zúñiga MC; Chedraui P
Maturitas; 2012 Aug; 72(4):359-66. PubMed ID: 22717489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
